Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04181255 · ClinicalTrials.gov registry record · Phase 1
Cold Heart Study: A Randomized Pilot Trial of Surfactant Therapy
A Phase 1 study, sponsored by University of Michigan.
- Terminated
- Registry status
- Phase 1
- Development phase
- 2
- Enrollment target
NCT04181255 is a Phase 1 study that was terminated before completion, run by University of Michigan. The registered enrollment target is 2 participants.
The verdict
NCT04181255, a Phase 1 study, was terminated before completion, sponsored by University of Michigan.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 2 participants
- Enrollment target
Study Summary
This clinical trial is being done to see if giving surfactant (Curosurf®) will decrease the number of days that infants will need a breathing tube, decrease the days in the critical care unit and decrease the number of days needed in the hospital. The primary hypothesis for this study is that there will be fewer days needed on mechanical ventilation and improved lung compliance and pulmonary gas exchange.
Interventions
- DRUG Sham
- DRUG Curosurf
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2020-02-25 |
| Est. Completion | 2020-06-12 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04181255
The ClinicalTrials.gov registry entry for NCT04181255 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 2 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Sham is the first listed.
NCT04181255 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04181255 about?
NCT04181255 is a clinical study titled "Cold Heart Study: A Randomized Pilot Trial of Surfactant Therapy". This clinical trial is being done to see if giving surfactant (Curosurf®) will decrease the number of days that infants will need a breathing tube, decrease the days in the critical care unit and decrease the number of days needed in the hospital. The primary hypothesis for this study is that there ...
What is the current status of trial NCT04181255?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 2 participants. The study started on 2020-02-25. Estimated completion is 2020-06-12.
What interventions are being tested in trial NCT04181255?
The interventions under investigation include: Sham (DRUG), Curosurf (DRUG).
Who is sponsoring clinical trial NCT04181255?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.